Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

The American Red Cross is hosting a blood drive on later this week to honor a 15-year-old Wisconsin boy who is battling a ...

Whitehawk Therapeutics, Inc. , formerly known as Aadi Bioscience, Inc., an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ...